top of page
Developing safe, convenient, disease-modifying treatments for food allergies.
Profile
Join date: Jun 4, 2018
Posts (27)
Jan 20, 2025 ∙ 2 min
Aravax Continues International Expansion with Appointment of Aled Williams as Chief Business Officer
Melbourne, Australia and Oxford, UK– 21 January 2025 , Aravax, a clinical-stage biotechnology company developing precisely targeted...
330
0
Nov 13, 2024 ∙ 2 min
Aravax Establishes Pharmaceutical Development base on the Oxford Science Park with a Focus on Developing Manufacturing Capabilities in the UK
Melbourne, Australia and Oxford, UK– 14 November 2024, Aravax, a clinical-stage biotechnology company developing next-generation...
476
0
Oct 28, 2024 ∙ 2 min
Aravax Completes Recruitment into Phase 2 Study of PVX108, a novel immunotherapy for the Treatment of Peanut Allergy
Melbourne, Australia – 28 October 2024: Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies...
498
0
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.
bottom of page